Mumbai, April 23, 2025: ART Fertility Clinics, a global leader in reproductive medicine, partnered with the Mumbai Obstetric & Gynecological Society (MOGS) to host the Annual Conference 2025 – Lab to Life in Mumbai. The event convened top international and Indian experts to discuss the latest developments in gynecology, embryology, and Assisted Reproductive Technology (ART).
With its advanced labs and a team of globally recognized fertility specialists, ART Fertility Clinics India provides personalized, evidence-based reproductive care with high success rates.
The conference featured sessions on ovarian stimulation, stem cell applications, the impact of paternal aging, and the uterine environment—addressing challenges like thin endometrium and adenomyosis. Experts also explored innovations in ART labs, AI in embryology, and in vitro maturation (IVM).
Key speakers included Prof. Dr. Human Fatemi, Prof. Dr. Barbara Lawrenz, Prof. Dr. Mustafa Baris Ata, Dr. Laura Melado Vidales, and Dr. Ameet Patki, along with Indian experts like Dr. Sujata Dalvi, Dr. Meenakshi Dua, Dr. Akash Surana, and Dr. Rajvi Mehta. Attendees included clinicians, embryologists, researchers, and medical students.
Built on clinical excellence, ART Fertility Clinics is known for its ESHRE-certified specialists and research-led practices, delivering elevated live birth rates across patient profiles.
Prof. Dr. Human Fatemi, Group Medical Director, ART Fertility Clinics, said, “At ART Fertility Clinics, helping patients achieve parenthood is at the heart of everything we do… we aim to combine science with hope and engage India’s medical community in helping patients fulfill their dream of parenthood.”
Dr. Somesh Mittal, CEO, ART Fertility Clinics India, added, “Our eleven state-of-the-art clinics bring global standards of fertility care to India… consistently leading to higher pregnancy outcomes.”
Dr. Parul Katiyar, Medical Director, ART Fertility Clinics India, shared, “Since our launch in 2021, the journey has been full of learnings… Our focus on research and personalized care allows us to extend the benefits of global expertise to every patient.”
